What is Biohaven's AOCI?

Biohaven (BHVN) reported AOCI of $8.3M in Q1 2026.

How has Biohaven's AOCI changed year-over-year?

Biohaven's AOCI increased by 11272.6% year-over-year, from $73K to $8.3M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Biohaven BHVN AOCI

AOCI at other companies

Eli LillyLLY

-$2.83B+24.9%

Xenon PharmaceuticalsXENE

-$1.21M-44.9%

Rapport Therapeutics, Inc.RAPP

-$505K-432%

Vir Biotechnology, Inc.VIR

-$3.48M-76.4%

uniQureQURE

-$59.89M-11.3%

Roivant SciencesROIV

$4.36M-53.8%

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.25B-48.1%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's AOCI?: Biohaven (BHVN) reported AOCI of $8.3M in Q1 2026.
How has Biohaven's AOCI changed year-over-year?: Biohaven's AOCI increased by 11272.6% year-over-year, from $73K to $8.3M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.